SEARCH

SEARCH BY CITATION

References

  • Ames B. N., Shigenaga M. K. and Hagen T. M. (1993) Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl Acad. Sci. U S A 90, 79157922.
  • Ayata C., Ayata G., Hara H. et al. (1997) Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J. Neurosci. 17, 69086917.
  • Barthwal M. K., Srivastava N. and Dikshit M. (2001) Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in rat. Redox Report 6, 297302.
  • Beagles K. E., Morrison P. F. and Heyes M. P. (1998) Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis. J. Neurochem. 70, 281291.
  • Beal M. F. (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23, 298304.
  • Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., SwartZ K. J. and Martin J. B. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321, 168171.
  • Beal M. F., Brouillet E., Jenkins G. G., Henshaw R., Rosen B. and Hyman B. T. (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61, 11471150.
  • Behan W. M., McDonald M., Darlington L. G. and Stone T. W. (1999) Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br. J. Pharmacol. 128, 17541760.
  • Birch-Machin M. A., Briggs H. L., Saborido A. A., Bindoff L. A. and Turnbull D. M. (1994) An evaluation of the measurement of the activities of complexes I–IV in the respiratory chain of human skeletal muscle mitochondria. Biochem. Med. Metab. Biol. 51, 3542.
  • Bordelon Y., MacKenzie L., McLaughlin B.-A. and Chesselet M.-F. (1994) Excitotoxic lesions of rat striatum: time course of DNA damage assessed by in situ nick translation. Soc. Neurosci., Abstract. 20, 988.
  • Bordelon Y. M., Chesselet M. F., Nelson D., Welsh F. and Erecinska M. (1997) Energetic dysfunction in quinolinic acid-lesioned rat striatum. J. Neurochem. 69, 16291639.
  • Bordelon Y. M., Chesselet M. F., Erecinska M. and Silver I. A. (1998) Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo. Neuroscience 83, 459469.
  • Brennan W. A., Bird. E. D. and Aprille J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 19481950.
  • Brewer G. J. and Wallimann T. W. (2000) Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 74, 19681978.
  • Browne S. E., Bowling A. C., MacGravey U., Baik M. J., Berger S. C., Muqit M. M., Bird E. D. and Beal M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646653.
  • Brusque A. M., Borba Rosa R., Schuck P. F. et al. (2002) Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem. Int. 40, 593601.
  • Brustovetsky N., Brustovetsky T. and Dubinsky J. M. (2001) On the mechanisms of neuroprotection by creatine and phosphocreatine. J. Neurochem. 76, 425434.
  • Buisson A., Plotkine M. and Boulu R. G. (1992) The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br. J. Pharmacol. 106, 766767.
  • Burton G. W., Wronska U., Stone L., Foster D. O. and Ingold K. U. (1990) Biokinetics of dietary RRR-α-tocopherol in the male guinea pig at three dietary levels of Vitamin C and two levels of Vitamin E. Lipids 25, 199210.
  • Cardoso S. M., Pereira C. and Oliveira R. (1999) Mitochondrial function is differentially affected upon oxidative stress. Free Radic. Biol. Med. 26, 313.
  • Cassina A. and Radi R. (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 328, 309316.
  • Ciani E., Baldinotti I. and Contestabile A. (2001) Sustained, long-lasting inhibition of nitric oxide synthase aggravates the neural damage in some models of excitotoxic brain injury. Brain Res. Bull. 56, 2935.
  • Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. U S A 88, 63686371.
  • Delwing D., Tagliari B., Streck E. L., Wannmacher C. M. D., Wajner M. and Wyse A. T. S. (2003) Reduction o energy metabolism in rat hippocampus by arginine administration. Brain Res. 983, 5863.
  • Dora C. D., Koch S., Sanches A., Ruenes G., Liu S. and Yezierski R. P. (1998) Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat. J. Neurotrauma 15, 473483,.
  • Dutra-Filho C. S., Wajner M., Wannmacher C. M., Gassen E., Candiago R. H., Wilhelms A. M. and De Malfussi H. F. (1995) 2-hydroxybutyrate and 4-hydroxybutyrate inhibit CO2 formation from labeled substrates by rat cerebral cortex. Biochem. Soc. Trans. 23, 228S.
  • Ferrante R. J., Kowall N. W., Cipolloni P. B., Storey E. and Beal M. F. (1993) Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp. Neurol. 119, 4671.
  • Fischer J. C., Ruitenbeek W., Berden J. A., Trijbels J. M., Veerkamp J. H., Stadhouders A. M., Sengers R. C. and Janssen A. J. (1985) Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 153, 2326.
  • Foster A. C., Collins J. F. and Schwarcz R. (1983) On the excitotoxic properties of quinolinic acid, 2,3-piridine dicarboxylic acid and structurally related compounds. Neuropharmacology 22, 13311342.
  • Franzon R., Lamers M. L., Stefanello F. M., Wannmacher C. M., Wajner M. and Wyse A. T. (2003) Evidence that oxidative stress is involved in the inhibitory effect of praline on Na+,K+-ATPase activity in synaptic plasma membrane of rat hippocampus. Int. J. Dev. Neurosci. 21, 303307.
  • Fukui S., Schwarcz R., Rapoport R. I., Takada Y. and Smith Q. R. (1991) Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J. Neurochem. 56, 20072017.
  • Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M. and Schapira A. H. V. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385389.
  • Halperin J. J. and Heyes M. P. (1992) Neuroactive kynurenines in Lyme borreliosis. Neurology 42, 4350.
  • Heyes M. P. (1987) Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I. Can. J. Neurol. Sci. 14, 441443.
  • Heyes M. P., Achim C. L., Wiley C. A., Major E. O., Saito K. and Markey S. P. (1996) Human microglia convert 1-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 320, 595597.
  • Heyes M. P., Brew B. J., Martin A. et al. (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29, 202209.
  • Heyes M. P., Saito K., Crowley J. S. et al. (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115, 12491273.
  • Heyes M. P., Saito K., Milstien S. and Schiff S. J. (1995) Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children. J. Neurol. Sci. 133, 112118.
  • Hughes B. P. (1962) A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta 7, 597603.
  • Kernec F., Le Tallec N., Nadal L., Begue J. M. and Le Rumeur E. (1996) Phosphocreatine synthesis by isolated rat skeletal muscle mitochondria is not dependent upon external ADP: a 31P NMR study. Biochem. Biophys. Res. Commun. 225, 819825.
  • Khodorov B., Pinelis V., Vergun O., Storozhevykh T. and Vinskaya N. (1996) Mitochondrial deenergization underlies neuronal calcium overload following a prolonged glutamate challenge. FEBS Lett. 397, 230234.
  • Kurosaki R., Muramatsu Y., Michimata M., Matsubara M., Kato H., Imai Y., Itoyama Y. and Araki T. (2002) Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol. Res. 24, 655662.
  • Kuzhikandathil E. V. and Molloy G. R. (1994) Transcription of the brain creatine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase. J. Neurosci. Res. 39, 7082.
  • Latini A., RodrigueZ M., Borba Rosa R. et al. (2005) 3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience 135, 111120.
  • Leipnitz G., Schumacher C., Scussiato K., Dalcin K. B., Wannmacher C. M., Wyse A. T., Dutra-Filho C. S., Wajner M. and Latini A. (2005) Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats. Int. J. Dev. Neurosci. 23, 695701.
  • Li Q. Y., Pedersen C., Day B. J. and Patel M. (2001) Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. J. Neurochem. 78, 746755.
  • Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265275.
  • Ludolph A. C., He F., Spencer P. S., Hammerstad J. and Sabri M. (1990) 3-Nitropropionic acid: exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492498.
  • Margaill I., Allix M., Boulu R. G. and Plotkine M. (1997) Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats. Br. J. Pharmacol. 120, 160163.
  • Matthews R. T., Yang L., Jenkins B. G. et al. (1998) Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J. Neurosci. 18, 156163.
  • Mitani A., Takeyasu S., Yanase H., Nakamura Y. and Kataoka K. (1994) Changes in intracellular Ca2+ and energy levels during in vitro ischemia in the gerbil hippocampal slice. J. Neurochem. 62, 626634.
  • Nishikawa T., Kirsch J. R., Koehler R. C., Bredt S. D., Snyder S. H. and Traystman R. J. (1993) Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke 24, 17181724.
  • Noack H., Lindenau J., Rothe F., Asayama K. and Wolf G. (1998) Differential expression of superoxide dismutase isoforms in neuronal and glial compartments in the course of excitotoxically mediated neurodegeneration relation to oxidative and nitrergic stress. Glia 23, 285297.
  • O'Gorman E., Beutner G., Wallimann T. and Brdiczka D. (1996) Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain. Biochim. Biophys. Acta 1276, 161170.
  • Obrenovitch T. P. (2001) Quinolinic acid accumulation during neuroinflammation. Does it imply excitotoxicity? Ann. NY Acad. Sci. 939, 110.
  • Obrenovitch T. P. and Urenjak J. (2003) Accumulation of quinolinic acid with neuroinflammation: does it mean excitotoxicity? Adv. Exp. Med. Biol. 527, 147154.
  • Ogawa T., Matson W. R., Beal M. F., Myers R. H., Bird E. D., Milbury P. and Saso S. (1992) Kynurenine pathway abnormalities in Parkinson's disease. Neurology 42, 17021706.
  • Paradies G., Petrosillo G., Pistolese M. and Ruggiero F. M. (2001) Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles. Mitochondrion 1, 151159.
  • Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic Press, San Diego.
  • Perez-Severiano F., Escalante B. and Rios C. (1998) Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem. Res. 23, 12971302.
  • Perez-Severiano F., Rodriguez-PereZ M., Pedraza-Chaverri J. et al. (2004) S-allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem. Int. 45, 11751183.
  • Qin Y., Soghomonian J.-J. and Chesselet M.-F. (1992) Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats. Exp. Neurol. 115, 200211.
  • Rios C. and Santamaria A. (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 16, 11391143.
  • Rustin P., Chretien D., Bourgeron T., Gerard B., Rotig A., Saudubray J. M. and Munnich A. (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228, 3551.
  • Ryu J. K., Kim S. U. and McLarnon J. G. (2003) Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease. Exp. Neurol. 183, 700704.
  • Ryu J. K., Kim S. U. and McLarnon J. G. (2004) Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease. Exp. Neurol. 187, 150159.
  • Santamaria A. and Rios C. (1993) MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci. Lett. 159, 5154.
  • Santamaria A., Jiménez-Capdeville M. E., Camacho A., Rodríguez-Martínez E., Flores A. and Galván-Arzate S. (2001) In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. Neuroreport 12, 26932696.
  • Schmidt W., Wolf G., Calka J. and Schmidt H. H. (1995) Evidence for bidirectional changes in nitric oxide synthase activity in rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neuroscience 67, 345356.
  • Schwarcz R., Whetsell W. O. Jr and Mangano R. M. (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219, 316318.
  • Schwarcz R., Foster A. C., French E. D., Whetsell W. O. Jr and Kohler C. (1984) Excitotoxic models for neurodegenerative disorders. Life Sci. 35, 1932.
  • Sharma H. S., Badgaiyan R. D., Alm P., Mohanty S. and Wiklund L. (2005) Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat. Ann. N Y Acad. Sci. 1053, 422434.
  • Shepherd D. and Garland P. B. (1973) Citrate synthase from rat liver. Meth. Enzymol. 13, 1116.
  • Da Silva C. G., Ribeiro C. A., LeipnitZ G., Dutra-Filho C. S., Wyse A. T., Wannmacher C. M., Sarkis J. J., Jakobs C. and Wajner M. (2002) Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim. Biophys. Acta 1586, 8191.
  • Da Silva C. G., Bueno A. R., Schuck P. F. et al. (2004) Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neurochem. Int. 44, 4552.
  • Singh S., Das T., Ravindran A., Chaturvedi R. K., Shukla Y., Agarwal A. K. and Dikshit M. (2005) Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease. Redox Report 10, 103109.
  • Stachowiak O., Dolder M., Wallimann T. and Richter C. (1998) Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 273, 1669416699.
  • Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309379.
  • Stone T. W. (2001) Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64, 185218.
  • Stone T. W., Mackay G. M., Forrest C. M., Clark C. J. and Darlington L. G. (2003) Tryptophan metabolites and brain disorders. Clin. Chem. Lab. Med. 41, 852859.
  • Stout A. K., Raphael H. M., KanterewicZ B. I., Klann E. and Reynolds I. J. (1998) Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat. Neurosci. 1, 366373.
  • Susel Z., Engber T. M. and Chase T. N. (1989) Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements. Neurosci. Lett. 104, 125129.
  • Tabrizi S. J., Cleeter M. W., Xuereb J., Taanman J. W., Cooper J. M. and Schapira A. H. (1999) Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol. 45, 2532.
  • Tavares R. G., Tasca C. I., Santos C. E., Wajner M., Souza D. O. and Dutra-Filho C. S. (2000) Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain. Neuroreport 11, 249253.
  • Tsuji K., Nakamura Y., Ogata T., Shibata T. and Kataoka K. (1994) Rapid decrease in ATP content without recovery phase during glutamate-induced cell death in cultured spinal neurons. Brain Res. 662, 289292.
  • Varadkar S. and Surtees R. (2004) Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis. J. Inherit. Metab. Dis. 27, 835842.
  • Vasques V. C., Brinco F. and Wajner M. (2005) Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks. J. Neurol. Sci. 232, 1121.
  • Wallimann T. and Hemmer W. (1994) Creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133–134, 193220.
  • Whetsell W. O. Jr and Schwarcz R. (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97, 271275.
  • Widner B., Leblhuber F., Walli J., Tilz G. P., Demel U. and Fuchs D. (1999) Degradation of tryptophan in neurodegenerative disorders. Adv. Exp. Med. Biol. 467, 133138.
  • Woodruff G.-N., Foster A. C., Gill R., Kemp J. A., Wong E. H. and Iversen L. L. (1987) The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology 26, 903909.
  • Zhang Y., Marcillat O., Giulivi C., Ernster L. and Davies K. J. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265, 16 33016 336.
  • Zhu S., Li M., Figueroa B. E. et al. (2004) Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J. Neurosci. 24, 59095912.